TLR8 and neoplasm: Most importantly, our results clearly showed that TLR8 signaling can prevent the cAMP production by tumor cells and block tumor-induced conversion of naïve and tumor-specific T cells into senescent cells, resulting in enhanced anti-tumor immunity in vivo.